NDC 69981-712

CUREFINI

Petrolatum, Cod Liver

CUREFINI is a Topical Ointment in the Human Otc Drug category. It is labeled and distributed by Rev Pharma Corp.. The primary component is Petrolatum; Cod Liver Oil.

Product ID69981-712_618470c1-de3f-9868-e053-2a91aa0a6a8d
NDC69981-712
Product TypeHuman Otc Drug
Proprietary NameCUREFINI
Generic NamePetrolatum, Cod Liver
Dosage FormOintment
Route of AdministrationTOPICAL
Marketing Start Date2013-01-17
Marketing CategoryOTC MONOGRAPH FINAL / OTC MONOGRAPH FINAL
Application Numberpart347
Labeler NameRev Pharma Corp.
Substance NamePETROLATUM; COD LIVER OIL
Active Ingredient Strength300 mg/mL; mg/mL
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 69981-712-64

120 mL in 1 JAR (69981-712-64)
Marketing Start Date2013-01-17
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 69981-712-64 [69981071264]

CUREFINI OINTMENT
Marketing CategoryOTC monograph final
Application Numberpart347
Product TypeHUMAN OTC DRUG
Marketing Start Date2013-01-17

NDC 69981-712-65 [69981071265]

CUREFINI OINTMENT
Marketing CategoryOTC monograph final
Application Numberpart347
Product TypeHUMAN OTC DRUG
Marketing Start Date2013-01-17

Drug Details

Active Ingredients

IngredientStrength
PETROLATUM300 mg/mL

OpenFDA Data

SPL SET ID:cefe35e8-77e3-4c3a-be28-89e2057d9466
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1440007
  • NDC Crossover Matching brand name "CUREFINI" or generic name "Petrolatum, Cod Liver"

    NDCBrand NameGeneric Name
    65121-712Curefinipetrolatum, cod liver
    69981-712CUREFINIPETROLATUM, COD LIVER
    79974-202CUREFINIPetrolatum, Cod Liver Oil
    69981-710CURACID Dermal for cuts and burnsPETROLATUM, COD LIVER
    69981-704CUREFINI DermalPETROLATUM, COD LIVER
    69981-754Curefini DermalPETROLATUM, COD LIVER
    65121-208Senophile DermalPETROLATUM, COD LIVER

    Trademark Results [CUREFINI]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    CUREFINI
    CUREFINI
    85691942 4409741 Live/Registered
    REV PHARMA CORPORATION
    2012-07-31

    © 2022 FDA.report
    This site is not affiliated with or endorsed by the FDA.